Feb 2 (Reuters)-
Immuno Biological Laboratories Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2017 Dec 31, 2016 Mar 31, 2018
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 504 mln 511 mln 773 mln
(-1.3 pct) (+5.6 pct) (+4.2 pct)
Operating loss 66 mln loss 183 mln loss 116 mln
Recurring loss 62 mln loss 195 mln loss 122 mln
Net loss 68 mln loss 199 mln loss 128 mln
EPS loss 9.22 yen loss 27.41 yen loss 17.25 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Immuno Biological Laboratories Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T
((Tokyo Headline News Desk +813 6441 1812))